se of calcium carbonate supplementation to prevent Pre-eclampsia in pregnant women high risk:randomized clinical trial

Not Applicable

• Conditions: nspecified pre-eclampsia; C12.050.703.634

• Registration Number: RBR-7hqhj3y
• Lead Sponsor: Centro de Ciências Biológicas e da Saúde - Universidade Federal de Sergipe

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-11-16
• Last Update Posted: 19 December 2023
• Study Completion: 2026-04-30

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: Female
• Target Recruitment: Not specified

Inclusion Criteria

Pregnant women who are up to the 20th week of pregnancy at the first stage of the approach; minumium age of 15 years; who present one or more of the risk factors: history of pre-eclampsia, multiple pregnancy, chronic hypertension, type 1 or 2 diabetes, autoimmune disorder) will be included in the study. , kidney disease, nulliparity, body mass index >30 kg/m2, family history of preeclampsia (first-degree relative), sociodemographic characteristics (African American, low socioeconomic status), age >35 years, history factors (pre-low birth weight or small birth for gestational age, previous adverse pregnancy outcome, interval >10 years since previous pregnancy, term birth without previous complications) for the occurrence of pre-eclampsia; and/or low intake of calcium

Exclusion Criteria

Pregnant women with known placental abnormalities; current pregnancy as a result of in vitro fertilization; regular use of platelet-active drugs; known fetal abnormalities; uterine bleeding documented within one week of screening; uterine malformations; pregnant women with chronic systemic hypertension; sickle cell anemia; those under 15 years of age

Study & Design

• Study Type: Intervention
• Study Design: Not specified